Cogent Biosciences

Cogent Biosciences COGT Stock

$28.56   -1.990391%
Add to favorites
Market Cap
$4.97B
LOW - HIGH [24H]
$28.45 - $29.02
VOLUME [24H]
$1.15M
P/E Ratio
0
Earnings per share
-$2.26
ISIN
US19240Q2012
Price   Prediction

Cogent Biosciences Price Chart

Sorry, that's all we've gotfor now...

Cogent Biosciences (COGT) stock price today is 28.56 USD on Tech Market Large (-1.99% on the day). Updated .

Cogent Biosciences COGT Financial and Trading Overview

Cogent Biosciences stock price 28.56 USD
Previous Close 29.14 USD
Open 29.01 USD
Bid 20.49 USD x 200
Ask 36.68 USD x 200
Day's Range 28.45 - 29.02 USD
52 Week Range 27.74 - 43.73 USD
Volume 1.15M USD
Avg. Volume 2.02M USD
Market Cap 4.97B USD
Beta (5Y Monthly) 0.341
PE Ratio (TTM) N/A
EPS (TTM) -2.26 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est 55.82 USD

COGT Valuation Measures

Enterprise Value 4.49B USD
Trailing P/E N/A
Forward P/E -22.46908
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) 8.409894
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -10.678

Trading Information

Cogent Biosciences Stock Price History

Beta (5Y Monthly) 0.341
52-Week Change -13.11%
S&P500 52-Week Change 12.28%
52 Week High 43.73 USD
52 Week Low 27.74 USD
50-Day Moving Average 31.52 USD
200-Day Moving Average 35.35 USD

COGT Share Statistics

Avg. Volume (3 month) 2.02M USD
Avg. Daily Volume (10-Days) 2.37M USD
Shares Outstanding 173.99M
Float 173.03M
Short Ratio 8.16
% Held by Insiders 0.42%
% Held by Institutions 119.63%
Shares Short 17.42M
Short % of Float 10.07%
Short % of Shares Outstanding 10.00%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio N/A
Last Split Factor 1:4

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -42.021%
Return on Equity (ttm) -99.58%

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA -420355008 USD
Net Income Avi to Common (ttm) -407675008 USD
Diluted EPS (ttm) -411.92
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 791.13M USD
Total Cash Per Share (mrq) 4.55 USD
Total Debt (mrq) 244.22M USD
Total Debt/Equity (mrq) 47.31 USD
Current Ratio (mrq) 10.99
Book Value Per Share (mrq) 3.396

Cash Flow Statement

Operating Cash Flow (ttm) -324046016 USD
Levered Free Cash Flow (ttm) -191620496 USD

Profile of Cogent Biosciences

Country United States
State MA
City Waltham
Address 180 Third Avenue
ZIP 02451
Phone (617) 945-5576
Website https://www.cogentbio.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 258

Cogent Biosciences, Inc., a clinical-stage biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes bezuclastinib (CGT9486), a selective tyrosine kinase inhibitor in Phase 3 trial designed to target mutations within the KIT receptor tyrosine kinase, including KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors. The company also develops CGT4859, a reversible and selective fibroblast growth factor receptor 2 inhibitor in Phase 1 trial for patients with documented FGFR mutations, including advanced cholangiocarcinoma; CGT4255, a novel ErbB2 mutant program, which is focused on actionable and underserved mutations in a solid tumor systemic and CNS involved indications; and CGT6297, a Novel PI3Ka mutant-selective inhibitor. It has a licensing agreement with Plexxikon Inc. for the research, development, and commercialization of bezuclastinib. Cogent Biosciences, Inc. is headquartered in Waltham, Massachusetts.

Q&A For Cogent Biosciences Stock

What is a current COGT stock price?

Cogent Biosciences COGT stock price today per share is 28.56 USD.

How to purchase Cogent Biosciences stock?

You can buy COGT shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Cogent Biosciences?

The stock symbol or ticker of Cogent Biosciences is COGT.

Which industry does the Cogent Biosciences company belong to?

The Cogent Biosciences industry is Biotechnology.

How many shares does Cogent Biosciences have in circulation?

The max supply of Cogent Biosciences shares is 173.99M.

What is Cogent Biosciences Price to Earnings Ratio (PE Ratio)?

Cogent Biosciences PE Ratio is now.

What was Cogent Biosciences earnings per share over the trailing 12 months (TTM)?

Cogent Biosciences EPS is -2.26 USD over the trailing 12 months.

Which sector does the Cogent Biosciences company belong to?

The Cogent Biosciences sector is Healthcare.

Cogent Biosciences COGT included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
us US Tech Composite IXIC US 25136.27 USD —
-0.91
7.74B USD — 24872.41 USD — 25423.09 USD — — 7.74B USD —
us Stlmt ID US Tech Biotechnology NBX US 4000.62 USD —
-1.26
— — 3927.42 USD — 4148.65 USD — — — —
us US Tech Global Select Market Com NQGS US 12378.66 USD —
-0.9
— — 12248.6 USD — 12520.36 USD — — — —
us US Tech Biotechnology NBI US 7211.27 USD —
-0.5
— — 7149.19 USD — 7238.9 USD — — — —
us US Tech Health Care IXHC US 1368.29 USD —
-0.34
— — 1358.68 USD — 1373.65 USD — — — —
$2.2T
Total marketcap
$75.37B
Total volume
BTC 59.40%   •   ETH 10.11%
Dominance
Select currency